Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optimize Pediatric OCT Imaging

NCT: NCT06139523 · RECRUITING

NCT IDNCT06139523
StatusRECRUITING
Start Date2024-01-24
Completion2027-12
SponsorDuke University (OTHER)
First posted
Last updated

Brief Summary

Handheld optical coherence tomography (OCT) has become an important imaging modality to evaluate the pediatric retina. The objective of this pilot study is to compare a new contact OCT system (Theia Imaging) with an investigational noncontact OCT system (Duke Biomedical Engineering) to assess their ability to image the pediatric retina. The investigators hypothesize that the contact OCT system is superior in imaging larger areas of the retina (larger field-of-view), while it has similar resolution to image the retina substructures (non-inferior image quality).

Frequently Asked Questions

What is Optimize Pediatric OCT Imaging?

Optimize Pediatric OCT Imaging is a clinical trial registered under NCT06139523. Current status: RECRUITING.

What is the status of NCT06139523?

The current status of NCT06139523 (Optimize Pediatric OCT Imaging) is: RECRUITING.

When did Optimize Pediatric OCT Imaging start?

Optimize Pediatric OCT Imaging started on 2024-01-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.